Skip to main content
OpenTrials

Clinical trial condition

HIV-1 Infection

Explore clinical trials studying HIV-1 Infection. Study availability and eligibility vary by location and protocol.

182 public trials 1 recruiting study
Refine in advanced search Browse all conditions

HIV-1 Infection trial results

Completed

High Dose Vitamin D and Calcium for Bone Health in Individuals Initiating HAART

NCT01403051

Conditions
HIV-1 Infection
Locations
  • Alabama Therapeutics CRS (5801) Birmingham, Alabama, United States
  • Usc Crs (1201) Los Angeles, California, United States
  • UCLA CARE Center CRS (601) Los Angeles, California, United States
  • Stanford CRS (501) Palo Alto, California, United States
View all 39 locations
View Trial Details
Completed

Rifaximin as a Modulator of Microbial Translocation and Immune Activation

NCT01466595

Conditions
HIV-1 Infection
Locations
  • Alabama Therapeutics CRS (5801) Birmingham, Alabama, United States
  • UCLA CARE Center CRS (601) Los Angeles, California, United States
  • Stanford CRS (501) Palo Alto, California, United States
  • Ucsf Aids Crs (801) San Francisco, California, United States
View all 32 locations
View Trial Details
Completed

Switching From Efavirenz/Atripla to Rilpivirine Among Patients With Neurocognitive or Neuropsychological Side Effects

NCT02042001

Conditions
Anxiety Disorders, Behavior, Behavioral Symptoms, +9 more
Locations
  • Clinic of Infectious Diseases, AO San Gerardo Monza, MB, Italy
  • Spedali Civili - University of Brescia Brescia, Italy
  • Clinica di Malattie Infettive, Ospedale San Martino Genova, Italy
  • AO San Paolo - University of Milan Milan, Italy
View Trial Details
Completed

Sitagliptin for Reducing Inflammation and Immune Activation

NCT02513771

Conditions
HIV-1 Infection, Inflammation, Pathologic Processes, +1 more
Locations
  • University of Southern California (1201) Los Angeles, California, United States
  • UCLA CARE Center CRS (601) Los Angeles, California, United States
  • Harbor-UCLA Med. Ctr. CRS (603) Torrance, California, United States
  • Whitman Walker Health CRS (31791) Washington D.C., District of Columbia, United States
View all 16 locations
View Trial Details
Completed

Evaluating Pharmacokinetic Interactions With Vaginal Ring Contraceptives and ART

NCT01903031

Conditions
HIV-1 Infection
Locations
  • 31788 Alabama CRS Birmingham, Alabama, United States
  • University of Southern California LA (5048) Los Angeles, California, United States
  • David Geffen School of Medicine at UCLA NICHD CRS (5112) Los Angeles, California, United States
  • University of Colorado Denver NICHD CRS (5052) Aurora, Colorado, United States
View all 21 locations
View Trial Details
Completed

HPV Test-and-Treat-Strategy Versus Cytology-based Strategy for Prevention of CIN2+ in HIV-Infected Women

NCT01315353

Conditions
HIV-1 Infection
Locations
  • Gaborone Prevention/Treatment Trials CRS (12701) Gaborone, Botswana
  • Molepolole Prevention/Treatment Trials CRS (12702) Molepolole, Botswana
  • Les Centres GHESKIO CRS (30022) Port-au-Prince, Haiti
  • BJ Medical College CRS (31441) Pune, Maharashtra, India
View all 13 locations
View Trial Details
Completed

Dolutegravir Plus Lamivudine Dual Therapy in Treatment Naïve HIV-1 Patients

NCT02582684

Conditions
HIV-1 Infection
Locations
  • University of Southern California CRS (1201) Los Angeles, California, United States
  • UCLA CARE Center CRS (601) Los Angeles, California, United States
  • Ucsd, Avrc Crs (701) San Diego, California, United States
  • Harbor-UCLA Med. Ctr. CRS (603) Torrance, California, United States
View all 26 locations
View Trial Details

Related conditions